Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05320835 · ClinicalTrials.gov registry record · NA
A Setting Focus Overdose Prevention Intervention
A NA study of HIV Infections and HCV, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Recruiting
- Registry status
- NA
- Development phase
- 285
- Enrollment target
- 1
- Study location
NCT05320835 is a NA study of HIV Infections and HCV that is actively recruiting participants, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 285 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05320835, a NA study of HIV Infections and HCV, is actively recruiting participants, sponsored by Johns Hopkins Bloomberg School of Public Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 285 participants
- Enrollment target
- 1
- Study location
Study Summary
A pilot injection-setting targeted peer-driven intervention to reduce HIV and hepatitis C virus transmission and overdose risk behaviors among people who inject drugs (PWID).
Conditions Studied
Interventions
- BEHAVIORAL HIV, HCV and overdose prevention
Study Locations (1)
Maryland
- Lighthouse Studies at Peer Point - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2022-04-30 |
| Est. Completion | 2027-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05320835
The ClinicalTrials.gov registry entry for NCT05320835 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 285 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (36% lower). The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which HIV, HCV and overdose prevention is the first listed.
NCT05320835 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05320835 about?
NCT05320835 is a clinical study titled "A Setting Focus Overdose Prevention Intervention". A pilot injection-setting targeted peer-driven intervention to reduce HIV and hepatitis C virus transmission and overdose risk behaviors among people who inject drugs (PWID).
What is the current status of trial NCT05320835?
This trial is currently recruiting. It is a NA study. The enrollment target is 285 participants. The study started on 2022-04-30. Estimated completion is 2027-05-30.
What conditions does trial NCT05320835 study?
This clinical trial studies the following conditions: HIV Infections, HCV, Drug Overdose.
What interventions are being tested in trial NCT05320835?
The interventions under investigation include: HIV, HCV and overdose prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05320835?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05320835 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.